Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%: Retraction.
出版信息
Medicine (Baltimore). 2019 Oct;98(43):e17868. doi: 10.1097/MD.0000000000017868.
Abstract
摘要
相似文献
1
Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40%: Retraction.血管紧张素受体脑啡肽酶抑制剂对左心室射血分数高于40%的心力衰竭患者的影响：撤稿声明
Medicine (Baltimore). 2019 Oct;98(43):e17868. doi: 10.1097/MD.0000000000017868.
2
Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.射血分数保留的心力衰竭患者高敏肌钙蛋白T升高及血管紧张素受体脑啡肽酶抑制剂LCZ696治疗的影响
Circ Heart Fail. 2014 Nov;7(6):953-9. doi: 10.1161/CIRCHEARTFAILURE.114.001427. Epub 2014 Oct 2.
3
Angiotensin Receptor Neprilysin Inhibitor for Patients With Heart Failure and Reduced Ejection Fraction: Real-World Experience From Taiwan.血管紧张素受体脑啡肽酶抑制剂用于射血分数降低的心力衰竭患者：来自台湾的真实世界经验
J Cardiovasc Pharmacol Ther. 2020 Mar;25(2):152-157. doi: 10.1177/1074248419872958. Epub 2019 Sep 12.
4
Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction: Rationale and Design of the PARAGON-HF Trial.血管紧张素受体脑啡肽酶抑制剂治疗射血分数保留心力衰竭：PARAGON-HF 试验的原理和设计。
JACC Heart Fail. 2017 Jul;5(7):471-482. doi: 10.1016/j.jchf.2017.04.013. Epub 2017 Jun 26.
5
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trial.在射血分数保留的心力衰竭患者中，血管紧张素受体脑啡肽酶抑制剂 LCZ696 的降压作用和疗效的独立性：PARAMOUNT 试验分析。
Eur J Heart Fail. 2014 Jun;16(6):671-7. doi: 10.1002/ejhf.76. Epub 2014 Apr 1.
6
Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices.在植入式除颤设备连续远程监测下，比较血管紧张素-脑啡肽酶抑制与血管紧张素抑制对射血分数降低患者室性心律失常的影响。
Heart Rhythm. 2018 Mar;15(3):395-402. doi: 10.1016/j.hrthm.2017.11.012. Epub 2017 Nov 14.
7
Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction: A Paradigm for All?血管紧张素受体-中性肽链内切酶抑制在射血分数降低的心力衰竭中的应用：适用于所有人的范例？
JACC Heart Fail. 2016 Oct;4(10):823-825. doi: 10.1016/j.jchf.2016.07.013. Epub 2016 Sep 7.
8
Efficacy of Pharmacologic and Cardiac Implantable Electronic Device Therapies in Patients With Heart Failure and Reduced Ejection Fraction: A Systematic Review and Network Meta-Analysis.心力衰竭和射血分数降低患者的药物和心脏植入电子设备治疗效果：系统评价和网络荟萃分析。
Circ Arrhythm Electrophysiol. 2019 Jun;12(6):e006951. doi: 10.1161/CIRCEP.118.006951. Epub 2019 Jun 4.
9
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.血管紧张素受体-脑啡肽酶抑制剂与射血分数降低的心力衰竭中心血管生物标志物和心脏重构的关系。
Circ Heart Fail. 2021 Jun;14(6):e008410. doi: 10.1161/CIRCHEARTFAILURE.120.008410. Epub 2021 May 15.
10
Pharmacodynamic and pharmacokinetic effects of S086, a novel angiotensin receptor neprilysin inhibitor.S086 新型血管紧张素受体脑啡肽酶抑制剂的药效学和药代动力学效应。
Biomed Pharmacother. 2020 Sep;129:110410. doi: 10.1016/j.biopha.2020.110410. Epub 2020 Jun 20.
本文引用的文献
1
Effect of the angiotensin-receptor-neprilysin inhibitor in heart failure patients with left ventricular ejection fraction higher than 40.血管紧张素受体脑啡肽酶抑制剂对左心室射血分数高于40%的心力衰竭患者的影响。
Medicine (Baltimore). 2019 Sep;98(39):e17296. doi: 10.1097/MD.0000000000017296.
Zotero 插件